Amyloid fibril formation

normal

New_Member
Joined
Sep 15, 2024
Messages
75
Reaction score
176
Location
US
I've seen topics and posts going both ways on this.

It seems like PH needs to be under around 4-4.5 exactly to be considered safe for this.

However, a lot of people don't seem to think it's a risk either way and this is overblown etc.

Would love to know your thoughts on this.

I have some I got for free I'm considering stacking with my current tirz dose, but still researching.
 
megalith from the peptidetest.com discord has firmly scared me to death from ever considering cagri. i'm sure there's some others in here who have been keeping up with his rants over the past few weeks on it.

far be it for me to tell anyone what to do with their body, but i would try a lot of different options before reconsidering cagri again. splitting doses, stacking between sema/tirz/reta or just moving to reta by itself entirely come to mind for me.
 
personally I think it's fear mongering.

on another place where conversation exists... this was discussed. I think you were there.

1730691939568.png


Smart people mechanically stressed the peptide to force the formation of these demons and had little success.

Amilyn has a natural tendency to form fibrils. Cagri is an amylin analogue specifically designed to resist fibril formation.

That snippet above describes the mechanical stress they applied to Cagri to force the formation.

45 hours at high temp in a centrifuge

source: https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00565

bring this up to mega and he starts in on some proprietary formulation not found in research peps. Novo dual injectors with some magic ingredient... and other nonsense.

Personally, I will stick with peptides that are approved. I may cross the bridge to Reta, and hopefully it is approved by the FDA by then... but until then prices for Reta remain high and what I have is working.

Overall, I think this is an often unspoken risk of "research". China is shipping all these trial drugs and peptides to us. And we're like SLU-PP-332? Sweet! Almost no human trials (at least none I could find) and only research in mice... but gimme "exercise in a pill".

Just wait for them to be at least approved in some first world nation with modern healthcare. A conservative approach.
 
I did a fair amount of reading on this and I came to the conclusion that even if cagri could form these fibrils, it doesn't seem like they could work their way into the brain.
 
megalith from the peptidetest.com discord has firmly scared me to death from ever considering cagri. i'm sure there's some others in here who have been keeping up with his rants over the past few weeks on it.

far be it for me to tell anyone what to do with their body, but i would try a lot of different options before reconsidering cagri again. splitting doses, stacking between sema/tirz/reta or just moving to reta by itself entirely come to mind for me.
I’ll let you in on a secret: that guy loves to make shit up so people think he is smart. It’s a type of person who makes a home on discord, and he might just be the most severe case in our little corner. Don’t mistake quantity of words, which he most certainly delivers, for quality of words, which is lacking.
 
My sarcasm isn't pointed at anyone, but isn't NN in phase 3 trials for CagriSema? But supposedly it's well known that the cagrilinitide part causes fibrils.

I get that NN doesn't give a crap about us, but I'm sure they care about the bottom line. The study costs are already significant but the lawsuits would be enormous if they moved forward with Cagrilinitide knowing it would do harm.

Note, don't take cagrilinitide, while sitting in a sauna spinning around in circles. You'll die /s
 
My sarcasm isn't pointed at anyone, but isn't NN in phase 3 trials for CagriSema? But supposedly it's well known that the cagrilinitide part causes fibrils.

Can you point to any papers or studies confirming this?
 
@brentm What do you need a citation for? That NN is doing phase 3 trials of CagriSema or the "it's well known that the cagrilinitide part causes fibrils." because I don't believe it does create fibrils except under very extreme circumstances. 👍
 
personally I think it's fear mongering.

on another place where conversation exists... this was discussed. I think you were there.

View attachment 3394

Smart people mechanically stressed the peptide to force the formation of these demons and had little success.

Amilyn has a natural tendency to form fibrils. Cagri is an amylin analogue specifically designed to resist fibril formation.

That snippet above describes the mechanical stress they applied to Cagri to force the formation.

45 hours at high temp in a centrifuge

source: https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00565

bring this up to mega and he starts in on some proprietary formulation not found in research peps. Novo dual injectors with some magic ingredient... and other nonsense.

Personally, I will stick with peptides that are approved. I may cross the bridge to Reta, and hopefully it is approved by the FDA by then... but until then prices for Reta remain high and what I have is working.

Overall, I think this is an often unspoken risk of "research". China is shipping all these trial drugs and peptides to us. And we're like SLU-PP-332? Sweet! Almost no human trials (at least none I could find) and only research in mice... but gimme "exercise in a pill".

Just wait for them to be at least approved in some first world nation with modern healthcare. A conservative approach.

Thank you for continuing to circulate this source because the random people talking out of their a** about this subject when we have actual science is infuriating.

Cagri was designed to RESIST fibril formation and researchers did a lot of testing to make sure that was actually how it worked. You don't have to take Cagri if you're concerned, especially given that there are plenty of other options, but don't run around lying and trying to scare people
 
Megalith's arguing style is not the type that I find persuasive - I agree that there is a huge volume of words being blasted out, only a portion of it being well referenced, and then the rest of the messages being things we're supposed to take at face value just because some other portion is backed up by some documentation.

However, I do think it's important to clarify that while it is true that Cagri was designed to resist fibril formation, Novo Nordisk does still do it at specific PH levels as part of this process - PH levels I do not know if we are at in the grey market.

Now, it's possible that NN is just being careful keeping the pH at ~4 for their clinical trials with Cagri/CagriSema and that the other work is enough. But their patent for Cagri does state that it must be formulated between 3.5 and 4.5. https://patents.google.com/patent/WO2021144476A1/en

The ThT Assay stuff I find persuasive. But I also am curious as to why NN is adamant about the low pH. I'm not educated enough here to come to a strong enough personal conclusion, so I've decided to skip cagri for now.
 
Megalith's arguing style is not the type that I find persuasive - I agree that there is a huge volume of words being blasted out, only a portion of it being well referenced, and then the rest of the messages being things we're supposed to take at face value just because some other portion is backed up by some documentation.

However, I do think it's important to clarify that while it is true that Cagri was designed to resist fibril formation, Novo Nordisk does still do it at specific PH levels as part of this process - PH levels I do not know if we are at in the grey market.

Now, it's possible that NN is just being careful keeping the pH at ~4 for their clinical trials with Cagri/CagriSema and that the other work is enough. But their patent for Cagri does state that it must be formulated between 3.5 and 4.5. https://patents.google.com/patent/WO2021144476A1/en

The ThT Assay stuff I find persuasive. But I also am curious as to why NN is adamant about the low pH. I'm not educated enough here to come to a strong enough personal conclusion, so I've decided to skip cagri for now.

This is where I'm coming to with it. From what I understand, the PH needs to be exactly between 3.5-4.5 or it runs the risk of forming.

It seems like they are running phase 3 trials with it because they are able to manufacture it at a specific PH. We aren't really able to do that on the research side. From my understanding, part of the fibril formation resistance that was designed in is based on the PH balance.
 
When you do a scientific trial you have to make sure conditions are exactly the same, to see if the medicine works in a pattern, so you saying them doing this one specific thing makes all your concerns over forming amyloid fibril true. Unless the study says the reason they hit that Ph is specifically due to fibril forming. They didn't.

You are just speculating
 
This is where I'm coming to with it. From what I understand, the PH needs to be exactly between 3.5-4.5 or it runs the risk of forming.
Can gray market researchers simply adjust the PH with SB or AA to get into this range? 3.5 ph sounds like a spicy shot!
 
When you do a scientific trial you have to make sure conditions are exactly the same, to see if the medicine works in a pattern, so you saying them doing this one specific thing makes all your concerns over forming amyloid fibril true. Unless the study says the reason they hit that Ph is specifically due to fibril forming. They didn't.

You are just speculating
The patent explicitly states the pH must be a 3.5 to 4.5 for physical and chemical stability.

Instability is, from my understanding, what would cause the fibrils to form - see the details in the ThT Assay bit posted above where it also explicitly says they are testing the stability properties.
 
Last edited:
Can gray market researchers simply adjust the PH with SB or AA to get into this range? 3.5 ph sounds like a spicy shot!
This would help if the pH does need to be that low for stability, in that new fibrils shouldn't form. But my limited understanding from googling seems to indicate that amyloid-like fibrils would survive lyophilization, so if the the raw material pH was too high to prevent fibril formation they would likely still be present upon reconstitution.

But I am not a chemist and no one here should be taking my word as anything but my own layperson's extremely limited understanding. All I really know is that NN indicates in the patent that they formulate it at 3.5 to 4.5 for stability reasons. I have no real idea if there is any concern around fibrils forming, or if any fibrils that may form are actually harmful. Perhaps NN is just taking a 'better safe than sorry' approach. Or perhaps there are real concerns.

I want to be quite explicit in that I don't know the answer here, and I recommend everyone come to their own conclusions based on the information available, at least unless we get actual experts chiming in.
 
When you do a scientific trial you have to make sure conditions are exactly the same, to see if the medicine works in a pattern, so you saying them doing this one specific thing makes all your concerns over forming amyloid fibril true. Unless the study says the reason they hit that Ph is specifically due to fibril forming. They didn't.

You are just speculating

In the patent for the drug, they mention hitting that ph specifically due to fibrils forming.

Of course I'm speculating, this is a research forum isn't it? Lol. I don't think we're gonna have any of the actual scientists jumping in here to discuss.
 
So I worked doing a scientific project and we were super strict, so it's why I'm saying if the test don't bring up fibril it's most likely just keeping the same standard for medication.

For example I would use the same tempture, from the same water source everyday during the scientific study we did, why? Eliminate any reasons for skewed results. Less things to blame.

They say stability, but does that mean Fibrosis happens if it's not or does it just mean they want to now it's the exact age, reconstitution, pH, tempture etc?

Like I said not saying "don't be questioning" this, it's not approved, but so far I haven't had anything say otherwise.
 
Back
Top